European Pharma & Biotech Patent Litigation Year in Review: The Top 5 Most Critical Developments from 2021
Head of Patent Litigation Strategy
Bristows LLP (U.K)
Ruud van der Velden
Global pharmaceutical and biotech patent law is an ever-changing battleground, and the past twenty months only amplified existing struggles for control of increasingly competitive intellectual property rights. With a historic 2021 behind us, renowned thought leaders from the European life sciences patent bar will take stock of the most important developments from the past year, and offer best practices on how to manage increasing, overlapping, and uncertain risk factors.
Complete the form below to download the recording of the webinar.
How We Will Use Your Data
C5 Communications has not authorized the use or sale of its list by any outside organization. Anyone claiming to have our list is not legitimate.
If you decide that you no longer wish to receive information about our events and products, you can contact us any time at [email protected]. Each of our marketing communications (whether by email, phone, facsimile, post or SMS) will also include an appropriate and easy way for you to unsubscribe.
142 Cromwell Road
London SW7 4EF United Kingdom
T: +44 (0) 20 4532 2313
E: [email protected]